Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Disease Progression. Found 36 abstracts

no pagination
Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK. Central nervous system prophylaxis in diffuse large B-cell lymphoma. Eur J Haematol. 2016 Aug;97(2):108-20.
Bassi DE, Cenna J, Zhang J, Cukierman E, Klein-Szanto AJ. Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6). Mol Carcinog. 2015 Oct;54(10):1122-31.   PMCID: PMC4240754
Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development. Cancer prevention research (Philadelphia, Pa). 2015 Nov;8(11):1027-35.   PMCID: 4777304
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol. 2015 May;33(13):1482-90.   PMCID: PMC4404425
Masica DL, Li S, Douville C, Manola J, Ferris RL, Burtness B, Forastiere AA, Koch WM, Chung CH, Karchin R. Predicting survival in head and neck squamous cell carcinoma from TP53 mutation. Hum Genet. 2015 May;134(5):497-507.   PMCID: 4324386
Mehrazin R, Smaldone MC, Egleston B, Tomaszewski JJ, Concodora CW, Ito TK, Abbosh PH, Chen DY, Kutikov A, Uzzo RG. Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?. Urologic Oncology: Seminars and Original Investigations. 2015 Apr;33(4):167e7-167e12.   PMCID: PMC4417444
Motzer RJ, Rini BI, McDermott DF, Redman BG, Kuzel TM, Harrison MR, Vaishampayan UN, Drabkin HA, George S, Logan TF, Margolin KA, Plimack ER, Lambert AM, Waxman IM, Hammers HJ. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. J Clin Oncol. 2015 May;33(13):1430-7.   PMCID: PMC4806782
Obeid EI, Conzen SD. The role of adrenergic signaling in breast cancer biology. Cancer Biomark. 2013 Jan;13(3):161-9.
Fernandez SV, Snider KE, Wu YZ, Russo IH, Plass C, Russo J. DNA methylation changes in a human cell model of breast cancer progression. Mutat Res. 2010 Jun;688(1-2):28-35.   PMCID: PMC2872054
Xu XZ, Garcia MV, Li TY, Khor LY, Gajapathy RS, Spittle C, Weed S, Lessin SR, Wu H. Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol. 2010 Feb;23(2):187-96.   PMCID: PMC2827925
Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer. 2009 May;115(9):1859-66.
Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008 Mar;112(5):1051-7.
Crispen PL, Wong YN, Greenberg RE, Chen DY, Uzzo RG. Predicting growth of solid renal masses under active surveillance. Urol Oncol. 2008 Sep;26(5):555-9.
Hwang C, Giri VN, Wilkinson JC, Wright CW, Wilkinson AS, Cooney KA, Duckett CS. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor. Breast Cancer Res Treat. 2008 Jan;107(2):235-42.
Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer. 2008 Nov 15;113(10):2671-80.
de Cicco RL, Bassi DE, Benavides F, Conti CJ, Klein-Szanto AJ. Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression. Mol Carcinog. 2007 Aug;46(8):654-9.
Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Journal of Urology. 2006 Feb;175(2):425-31.
Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Diverse effects of zinc on NF-{kappa}B and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis. 2006 Oct;27(10):1980-90.
Langer CJ. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clinical lung cancer. 2005 Jan;6(5):314-6, 2005 Mar.
Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, Meropol NJ. Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol. 2003 Apr;21(7):1301-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Disease Progression

Disease Progression pathology Female Male metabolism drug therapy Middle Aged Kidney Neoplasms therapeutic use Renal Cell Carcinoma genetics Squamous Cell Carcinoma Treatment Outcome Disease-Free Survival Aged pharmacology Antineoplastic Combined Chemotherapy Protocols antagonists & inhibitors Tumor Cell Line Adult Skin Neoplasms Time Factors surgery Neoplasm Metastasis administration & dosage Prognosis adverse effects Signal Transduction mortality Proportional Hazards Models drug effects Monoclonal Antibodies methods 80 and over Aged Risk Factors Precancerous Conditions Retrospective Studies Cell Proliferation Cell Line Recurrence dosage Proprotein Convertases epidemiology Breast Neoplasms Antineoplastic Agents pa [Pathology] DNA Methylation Rituximab prevention & control Kaplan-Meier Estimate Pcsk6 Bone Neoplasms Zinc Lung Neoplasms Interleukin-6 Psychological Stress Liquid Chromatography Mutation Cytokine Receptor gp130 Cryosurgery Cytoskeleton Angiogenesis Inhibitors Melanoma proprotein convertases central nervous system involvement Vascular Endothelial Growth Factor A Survival Analysis Middle Age Transcription Factor AP-1 MAP Kinase Signaling System blood Vitamin D Deficiency bezo(a)pyrene toxicity Nevus skin carcinogenesis Carcinogenesis radiography NF-kappa B IGF Type 1 Receptor Local Neoplasm Recurrence Active surveillance central nervous system prophylaxis Intravenous Administration Finland Carcinogens Immunohistochemistry Spinal Injections Canada 0 (Imidazoles) Pancreatic Neoplasms 118072-93-8 (zoledronic acid) Incidence Renal cell carcinoma Cell Adhesion Prostatic Neoplasms Carrier Proteins Follow-Up Studies Tandem Mass Spectrometry Renal tumor Nephrometry Score et [Etiology] squamous cell carcinoma DNA-Binding Proteins Secondary Hypertrophic Osteoarthropathy 0 (Diphosphonates) Prospective Studies Imidazoles biosynthesis Prednisone Estradiol Diphosphonates Adrenergic beta-Antagonists Brain Neoplasms Algorithms physiopathology Adenocarcinoma US Gov't Support-PHS Italy Catheter Ablation Alkyl and Aryl Transferases Human CpG Islands United States immunology Mouth Neoplasms Interleukin-8 tumor progression Estrogen Receptors Kaplan-Meiers Estimate Polymerase Chain Reaction administration & DNA Sequence Analysis Fluorescence Microscopy Fluorescence In Situ Hybridization Biomarkers Watchful Waiting diagnosis Matrix Metalloproteinase 9 0 (Antineoplastic Combined Chemotherapy Protocols) chemically induced enzymology Genetic Transcription Adrenergic Receptors-beta CD274 Antigens physiology th [Therapy] Drug Dose-Response Relationship Quinolones
Last updated on Tuesday, October 10, 2017